Literature DB >> 889441

RNAs of influenza virus recombinants derived from parents of known virulence for man.

G Florent, M Lobmann, A S Beare, N Zygraich.   

Abstract

Extensive use of recombinants made from A/PR/8/34 (H0N1) and wild, virulent H3N2 viruses as live influenza vaccines has provided a number of viruses of defined virulence for man. Clinical symptoms produced by these strains have ranged from febrile influenza to local coryzal symptoms or nil. A study was therefore made of the extent to which the PR8 genome had been incorporated into that of a number of the recombinants. By RNA--RNA hybridization it seemed that recombinants which had 55 per cent of greater homology with the PR8 parent were likely to conform an acceptable standard of attenuation. Those with lesser homology were frequently, but not always, clinically virulent. The technique seemed potentially useful, therefore, for screening PR8 live vaccine recombinants in vitro before giving them to volunteers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889441     DOI: 10.1007/bf01314375

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Clinical trials with Alice strain, live, attenuated, serum inhibitor-resistant intranasal influenza A vaccine.

Authors:  M J Spencer; J D Cherry; K R Powell; C V Sumaya; A J Garakian
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

Review 2.  Live viruses for immunization against influenza.

Authors:  A S Beare
Journal:  Prog Med Virol       Date:  1975

3.  A reexamination of influenza single-and double-stranded RNAs by gel electrophoresis.

Authors:  M W Pons
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

4.  Purification and properties of the RNA polymerase-template complex of an influenza virus.

Authors:  R T Schwarz; C Scholtissek
Journal:  Z Naturforsch C       Date:  1973 Mar-Apr       Impact factor: 1.649

5.  Ribonucleic acid nucleotidyl transferase induced in chick fibroblasts after infection with an influenza virus.

Authors:  C Scholtissek; R Rott
Journal:  J Gen Virol       Date:  1969-01       Impact factor: 3.891

6.  Hybridization studies with influenza virus RNA.

Authors:  C Scholtissek; R Rott
Journal:  Virology       Date:  1969-11       Impact factor: 3.616

7.  Synthesis in vitro of RNA complementary to parental viral RNA by RNA polymerase induced by influenza virus.

Authors:  C Scholtissek
Journal:  Biochim Biophys Acta       Date:  1969-04-22

8.  Differences in RNA patterns of influenza A viruses.

Authors:  P Palese; J L Schulman
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

9.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

10.  Virulence for man of a human influenza-A virus antigenically similar to "classical" swine viruses.

Authors:  A S Beare; J W Craig
Journal:  Lancet       Date:  1976-07-03       Impact factor: 79.321

View more
  11 in total

1.  Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens.

Authors:  Diane J Hulse; Robert G Webster; Rupert J Russell; Daniel R Perez
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses for monkeys.

Authors:  M H Snyder; A J Buckler-White; W T London; E L Tierney; B R Murphy
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

3.  Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.

Authors:  A Delem; W Van Rensburg; I Flaskett
Journal:  J Hyg (Lond)       Date:  1979-10

Review 4.  Molecular basis of infectivity and pathogenicity of myxovirus. Brief review.

Authors:  R Rott
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 5.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

6.  Gene constellation of live influenza A vaccines.

Authors:  G Florent
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

7.  Trials of live influenza A recombinants in man during natural antigenic change in 1971-1976.

Authors:  A S Beare; A P Kendal; G C Schild
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

8.  Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.

Authors:  M Lobmann; A Delem; D Jovanovic; J Peetermans
Journal:  J Hyg (Lond)       Date:  1981-08

9.  Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses.

Authors:  M Hamzawi; R Jennings; C W Potter
Journal:  J Hyg (Lond)       Date:  1981-12

Review 10.  Reference viruses for seasonal and pandemic influenza vaccine preparation.

Authors:  John S Wood; James S Robertson
Journal:  Influenza Other Respir Viruses       Date:  2007-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.